成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

ChemicalBook Chinese Germany Japanese Korean

TargetMol中國（陶術(shù)生物） Company Information
Company Name:    TargetMol Chemicals Inc.
Tel:    -
Email:    marketing@targetmol.com
Nationality:    China
WebSite:    https://www.targetmol.cn/
Product List:    19704
75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179
Product List
Duocarmycin analog-2 1164275-01-7
10-Formyl-5,8-dideazafolic acid 61038-31-1
UNC4203 1818234-19-3
Sipagladenant 858979-50-7
Tubulin inhibitor 18 2762382-51-2
BRD3731 2056262-07-6
CC214-2 1228012-18-7
OTS964 1338542-14-5
Claficapavir 2055732-24-4
S 17092 176797-26-5
GSK2646264 1398695-47-0
XT2 2582816-37-1
CB1/2 agonist 3 2772655-86-2
Clevudine triphosphate 174625-00-4
(15aS)-1,15-Bis(diphenylphosphino)-7,8,9,10-tetrahydro-6H-dibenzo[b,d][1,6]dioxacycloundecine 486429-95-2
(15aR)-1,15-Bis(diphenylphosphino)-7,8,9,10-tetrahydro-6H-dibenzo[b,d][1,6]dioxacycloundecine 301847-91-6
4,4'-(Triaz-1-ene-1,3-diyl)dibenzimidamide hydrochloride 2331268-15-4
Methyl 3-(3-bromophenyl)-1,2-oxazole-5-carboxylate 377059-68-2
(16aR)-1,16-Bis(diphenylphosphino)-6,7,8,9,10,11-hexahydrodibenzo[b,d][1,6]dioxacyclododecine 301847-92-7
SARS-CoV-2 nsp13-IN-1 1005304-44-8
Nrf2 activator-4 2383016-68-8
NDB 1660153-08-1
Xanthine amine congener hydrochloride 1783977-95-6
Org 43553 501444-88-8
SMO-IN-3 2376914-71-3
PTP1B-IN-15 765317-71-3
CCT369260 2647503-57-7
Nezulcitinib 2412496-23-0
AGN 192870 166977-57-7
BACE-IN-1 1254166-60-3
Sulfinalol 66264-77-5
MK-8153 1548286-45-8
BRL-15572 hydrochloride 1173022-77-9
Epitinib 1203902-67-3
BI-10 2759037-58-4
Aspochalasin M 1173040-34-0
IXA6 1021106-40-0
HIV-1 inhibitor-31 920036-04-0
GRK6-IN-2 2677786-27-3
IAA65 2987139-96-6
Penamecillin 983-85-7
IM-93 1173657-73-2
Glyoxalase I inhibitor 2 2314467-61-1
ZINC09659342 1668604-47-4
PND-1186 hydrochloride 1356154-94-3
DG013A 2007955-07-7
Mytoxin B 105049-15-8
Glucametacine 52443-21-7
ML138 1355243-24-1
GSK2647544 1380426-95-8
ONO-9780307 856691-44-6
CDK5-IN-2 2639542-22-4
PI3K/mTOR Inhibitor-4 2361215-32-7
Ifetroban sodium 156715-37-6
GNF2133 hydrochloride 2561414-57-9
Darglitazone Sodium 149904-87-0
Regorafenib mesylate 835621-08-4
BMT-090605 hydrochloride 2231664-45-0
BSJ-01-175 2227392-55-2
Tubulin inhibitor 23 170488-57-0
ITK inhibitor 6 2404604-06-2
Ro 363 hydrochloride 250580-70-2
Sovesudil 1333400-14-8
NF-κB/MAPK-IN-1 2413940-56-2
Tripelennamine citrate 6138-56-3
HTT-D3 2254502-89-9
DS-6930 1242328-82-0
Quinine hydrobromide 549-49-5
Laniquidar 197509-46-9
DDO-02005 1186049-44-4
A2A receptor antagonist 3 2738606-83-0
BS-181 dihydrochloride 1883548-83-1
TXA6101 1459695-66-9
Efpeglenatide 1296200-77-5
ST247 1356497-91-0
CJ-2360 2226742-61-4
18-Deoxyherboxidiene 1200128-66-0
Paltimatrectinib 2353522-15-1
HAMI 3379 1245653-57-9
BMS-566419 566161-24-8
EHT 5372 1425945-63-6
ABC44 1831135-46-6
Edecesertib 2408839-73-4
GS-6620 PM 1191237-49-6
CB1R antagonist 1 334668-69-8
Vamotinib 1416241-23-0
RIPK3-IN-1 2361139-70-8
Tau-aggregation and neuroinflammation-IN-1 2175953-98-5
UCM-1306 2258608-78-3
Neldazosin 109713-79-3
DSS30 883027-32-5
PI3K-IN-38 1382979-64-7
BTA-188 314062-80-1
Camonagrel 105920-77-2
CQ211 2648986-65-4
CSF1R-IN-3 2760584-90-3
Bafrekalant 2256770-44-0
MCT1-IN-3 2878360-80-4
Ezurpimtrostat hydrochloride 1914148-73-4
WIN 54954 107355-45-3
75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179
Copyright 2007©  ChemicalBook. All rights reserved.